StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.20−0.12 (-9.09%)

Close on Nov 19, 2026Market cap $9.60MP/E –Yield –

PAVmed net income

Net income is the profit left for shareholders after every expense, interest and tax.

PAVmed's net income for the twelve months ending Jun 30, 2026 was -$12.09M, down 116.6% year over year. For fiscal 2025 it was $401.00K, down 99.0% from the year before. The highest annual figure on record is $39.79M in fiscal 2024.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$401.00K-99.0%
FY2024Dec 31, 2024$39.79M–
FY2023Dec 31, 2023-$64.18M–
FY2022Dec 31, 2022-$88.98M–
FY2021Dec 31, 2021-$50.35M–
FY2020Dec 31, 2020-$34.28M–
FY2019Dec 31, 2019-$16.46M–
FY2018Dec 31, 2018-$17.97M–
FY2017Dec 31, 2017-$9.52M–
FY2016Dec 31, 2016-$5.65M–
FY2015Dec 31, 2015-$1.78M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.38M–
Q1 FY2026Mar 31, 2026-$60.00K-100.3%
Q4 FY2025Dec 31, 2025-$1.26M-188.3%
Q3 FY2025Sep 30, 2025-$5.38M-108.4%
Q2 FY2025Jun 30, 2025-$11.92M–
Q1 FY2025Mar 31, 2025$18.97M–
Q4 FY2024Dec 31, 2024$1.43M–
Q3 FY2024Sep 30, 2024$64.40M–
Q2 FY2024Jun 30, 2024-$10.83M–
Q1 FY2024Mar 31, 2024-$15.21M–
Q4 FY2023Dec 31, 2023-$14.04M–
Q3 FY2023Sep 30, 2023-$17.67M–
Q2 FY2023Jun 30, 2023-$14.54M–
Q1 FY2023Mar 31, 2023-$17.93M–
Q4 FY2022Dec 31, 2022-$20.46M–
Q3 FY2022Sep 30, 2022-$26.13M–
Q2 FY2022Jun 30, 2022-$25.53M–
Q1 FY2022Mar 31, 2022-$16.87M–
Q4 FY2021Dec 31, 2021-$17.22M–
Q3 FY2021Sep 30, 2021-$12.23M–
Q2 FY2021Jun 30, 2021-$11.47M–
Q1 FY2021Mar 31, 2021-$9.43M–
Q4 FY2020Dec 31, 2020-$8.74M–
Q3 FY2020Sep 30, 2020-$5.48M–
Q2 FY2020Jun 30, 2020-$5.58M–
Q1 FY2020Mar 31, 2020-$14.48M–
Q4 FY2019Dec 31, 2019-$6.24M–
Q3 FY2019Sep 30, 2019-$3.09M–
Q2 FY2019Jun 30, 2019-$3.59M–
Q1 FY2019Mar 31, 2019-$3.54M–
Q4 FY2018Dec 31, 2018-$6.83M-885.4%
Q3 FY2018Sep 30, 2018-$3.25M–
Q2 FY2018Jun 30, 2018-$5.07M–
Q1 FY2018Mar 31, 2018-$2.83M–
Q4 FY2017Dec 31, 2017$869.84K–
Q3 FY2017Sep 30, 2017-$5.13M–
Q2 FY2017Jun 30, 2017-$989.71K–
Q1 FY2017Mar 31, 2017-$4.27M–
Q4 FY2016Dec 31, 2016-$1.71M–
Q3 FY2016Sep 30, 2016-$1.93M–

More PAVmed figures

See a number that looks wrong?